Product Program year 2025 Source: CMS Open Payments

Evis Exera III Xenon Light Source

Device Gastroenterology

PDI 04953170298868

Open in the dashboard

General payments

$482,543

47 payments

Research payments

$0

0 payments

Through program year 2025, $482,543 in general payments and $0 in research payments were reported against Evis Exera III Xenon Light Source (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $44,391 14
2024 General $25,835 11
2023 General $382,093 14
2022 General $30,224 8

Breakdown

Who paid General payments · program years 2022–2025
  1. Olympus Corporation of the Americas $403,693 11 payments
  2. Olympus America Inc. $78,817 35 payments
  3. Olympus Latin America, Inc. $34 1 payment
Top recipients General payments · program year 2025
  1. Adventhealth Orlando Teaching hospital · FL $13,239 30% · 1 payment
  2. Orlando Health Teaching hospital · FL $12,718 29% · 1 payment
  3. Medical University Of South Carolina Teaching hospital · SC $7,375 17% · 1 payment
  4. Stanley Dennison Interventional Pain Medicine · Tampa, FL $5,878 13% · 1 payment
  5. Kenneth Owen Cardiovascular Disease · Charlotte, NC $3,717 8% · 1 payment

The top 5 of 13 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Pain Medicine Pain Medicine $5,878 53% · 1 practitioner
  2. Cardiovascular Disease Internal Medicine $3,717 34% · 1 practitioner
  3. Gastroenterology Internal Medicine $1,444 13% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Florida $31,835 72% · 3 recipients
  2. South Carolina $7,375 17% · 1 recipient
  3. North Carolina $3,717 8% · 1 recipient
  4. Illinois $880 2% · 1 recipient
  5. Rhode Island $558 1% · 4 recipients

The top 5 of 8 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

47 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record